This study reports the rational design, synthesis, and in vitro biological evaluation of a novel series of pyridopyrimidine derivatives as potential anticancer agents targeting gastric cancer. The compounds were screened against the AGS gastric adenocarcinoma cell line To investigate the underlying mechanisms of action, a comprehensive label-free quantitative proteomics approach was employed. Differential protein expression analysis revealed key pathways modulated by the lead compound.